-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, oVynjisB3ZOyPNmdfl7b6KDdHUrJVQK92iNr5hqNnuKCwvs/azPFqI3/N+e+zFNg FXgo68onUhH1Huq49l+CWg== 0000319815-95-000005.txt : 19950428 0000319815-95-000005.hdr.sgml : 19950428 ACCESSION NUMBER: 0000319815-95-000005 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19950131 FILED AS OF DATE: 19950427 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXWELL LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000319815 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 952390133 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10964 FILM NUMBER: 95532043 BUSINESS ADDRESS: STREET 1: 8888 BALBOA AVE CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 6192795100 MAIL ADDRESS: STREET 2: 8888 BALBOA AVE CITY: SAN DIEGO STATE: CA ZIP: 92123 10-Q/A 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Amendment No. 1) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended January 31, 1995 Commission file Number 0-10964 MAXWELL LABORATORIES, INC. Delaware IRS ID# 95-2390133 8888 Balboa Avenue, San Diego, California 92123 Telephone (619) 279-5100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ] As of February 28, 1995 Registrant had only one class of common stock of which there were 2,674,973 shares outstanding. PART II - OTHER INFORMATION Item 6. Exhibits and Reports on Form 8-K ________________________________ (a) Exhibits ________ Exhibit 27 - Financial Data Schedule (b) Reports on Form 8-K ___________________ No reports on Form 8-K were filed during the quarter ended January 31, 1995. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MAXWELL LABORATORIES, INC. April 26, 1995 Gary J. Davidson Date Gary Davidson, Chief Financial Officer and Authorized Officer EX-27 2 ARTICLE 5 FINANCIAL DATA SCHEDULE FOR 2ND QUARTER 10-Q
5 This schedule contains summary financial information extracted from the Consolidated Condensed Balance Sheet and the Consolidated Condensed Statement of Income as filed in Item 1 on Form 10-Q and is qualified in its entirety by reference to such financial statements. 1,000 6-MOS JUL-31-1995 JAN-31-1995 1,724 0 15,375 0 8,869 29,858 55,935 35,239 51,924 11,537 2,341 267 0 0 35,253 51,924 35,548 35,548 25,992 25,992 2,290 0 0 889 284 560 0 0 0 560 .21 .21
-----END PRIVACY-ENHANCED MESSAGE-----